Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-09-11

Clinical Trial Update: Randomised Study to Compare the Effect of r-Hu-EPO Administration With Transfusion of Red Blood Cell Concentrates and Also With the Administration of Polyvitamins in Anemic and Tired Patients Presenting a Bad Prognostic in Middle Course [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing r-Hu-EPO with red blood cell transfusion and with polyvitamins in anemic, tired patients with poor prognosis; the study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polyvitamins (multivitamin preparation)
  • Red blood cell transfusion (erythrocyte concentrate)
  • r-Hu-EPO (recombinant human erythropoietin) (erythropoietin)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: - Medico-Economic Aspects (Evaluation of Medical Costs Related to the Three Strategies and Evaluation of Cost/Efficacy) | Phase 3 | Status: TERMINATED